Cell-free systems for vaccine production

Area of Science:

• Biotechnology
• Molecular Biology
• Vaccinology

Background:

• Cell-free (CF) systems utilize cellular machinery (tRNAs, ribosomes, polymerase) for in vitro protein synthesis.
• CF systems provide advantages over cell-based methods, including speed, biosafety, and portability.
• These systems are valuable for biosensing, diagnostics, protein production, synthetic biology, and vaccine development.

Purpose of the Study:

• To provide a comprehensive overview of cell-free system applications in biomedical sciences.
• To emphasize the role of CF systems in vaccine development and production.
• To discuss innovations addressing current limitations of CF platforms.

Main Methods:

• Review of existing literature on cell-free systems and their applications.
• Analysis of successful antigen expression from challenging pathogens (e.g., Plasmodium falciparum, Chlamydia muridarum, SARS-CoV-2).
• Exploration of emerging solutions for CF platform limitations.

Main Results:

• CF systems demonstrate successful antigen expression for difficult pathogens.
• Identified limitations include lack of post-translational modifications, endotoxin presence, and high cost.
• Promising innovations include glycoengineering, freeze-drying, exosome-based delivery, and machine learning integration.

Conclusions:

• Cell-free systems are a powerful and versatile platform for biomedical research and vaccine development.
• Innovations are actively addressing CF system limitations to expand their utility.
• Future directions involve advanced engineering and AI integration for optimized CF production pipelines.